Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N D Kauff

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Obstetrics and Gynecology|September 1, 1995
Intractable bleeding managed with Foley catheter tamponade after dilation and evacuationN D Kauff, D Chelmow, C Y Kawada
Gynecologic Oncology|September 18, 2009
A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancerO Zivanovic, J Carter, N D Kauff, et al.
Cancer|July 15, 2000
SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: data on 791 casesW E Khalbuss, D Rudomina, N D Kauff, et al.
Gynecologic Oncology|July 12, 2011
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and youngerK K Shih, K Garg, D A Levine, et al.
Clinical Genetics|June 9, 2011
Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genesL Zhang, M H Fleischut, K Kohut, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2001
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutationsN D Kauff, L Scheuer, M E Robson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivityD J Gallagher, J A Konner, K M Bell-McGuinn, et al.
Journal of Medical Genetics|August 6, 2002
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesN D Kauff, P Perez-Segura, M E Robson, et al.
Familial Cancer|May 26, 2006
Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissueM A Adank, E Brogi, F Bogomolniy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2014
The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancerJ L Meisel, D M Hyman, K Garg, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Obstetrics and Gynecology|September 1, 1995
Intractable bleeding managed with Foley catheter tamponade after dilation and evacuationN D Kauff, D Chelmow, C Y Kawada
Gynecologic Oncology|September 18, 2009
A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancerO Zivanovic, J Carter, N D Kauff, et al.
Cancer|July 15, 2000
SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: data on 791 casesW E Khalbuss, D Rudomina, N D Kauff, et al.
Gynecologic Oncology|July 12, 2011
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and youngerK K Shih, K Garg, D A Levine, et al.
Clinical Genetics|June 9, 2011
Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genesL Zhang, M H Fleischut, K Kohut, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2001
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutationsN D Kauff, L Scheuer, M E Robson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivityD J Gallagher, J A Konner, K M Bell-McGuinn, et al.
Journal of Medical Genetics|August 6, 2002
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesN D Kauff, P Perez-Segura, M E Robson, et al.
Familial Cancer|May 26, 2006
Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissueM A Adank, E Brogi, F Bogomolniy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2014
The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancerJ L Meisel, D M Hyman, K Garg, et al.
Pageof 1